DE69810332D1 - Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung - Google Patents

Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung

Info

Publication number
DE69810332D1
DE69810332D1 DE69810332T DE69810332T DE69810332D1 DE 69810332 D1 DE69810332 D1 DE 69810332D1 DE 69810332 T DE69810332 T DE 69810332T DE 69810332 T DE69810332 T DE 69810332T DE 69810332 D1 DE69810332 D1 DE 69810332D1
Authority
DE
Germany
Prior art keywords
methods
compositions
carbapeneme
antibacterial
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69810332T
Other languages
English (en)
Inventor
A Blizzard
W Ratcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806684.8A external-priority patent/GB9806684D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69810332D1 publication Critical patent/DE69810332D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE69810332T 1997-10-15 1998-10-13 Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung Expired - Lifetime DE69810332D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6212197P 1997-10-15 1997-10-15
GBGB9806684.8A GB9806684D0 (en) 1998-03-27 1998-03-27 Carbapenem antibacterial compounds, compositions containing such compounds and ethods of treatment
PCT/US1998/021593 WO1999018954A1 (en) 1997-10-15 1998-10-13 Antibacterial carbapenems, compositions and methods of treatment

Publications (1)

Publication Number Publication Date
DE69810332D1 true DE69810332D1 (de) 2003-01-30

Family

ID=26313381

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810332T Expired - Lifetime DE69810332D1 (de) 1997-10-15 1998-10-13 Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung

Country Status (7)

Country Link
EP (1) EP1023062B1 (de)
JP (1) JP2001519389A (de)
AT (1) ATE229804T1 (de)
AU (1) AU735124B2 (de)
CA (1) CA2306399A1 (de)
DE (1) DE69810332D1 (de)
WO (1) WO1999018954A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04003072A (es) * 2001-10-02 2004-09-06 Pharmacia Corp Procedimiento para preparar compuestos de bencenosulfonilo.
NO20053676D0 (no) * 2005-07-29 2005-07-29 Amersham Health As Crystallisation Process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756725A (en) * 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Also Published As

Publication number Publication date
AU1082499A (en) 1999-05-03
AU735124B2 (en) 2001-06-28
EP1023062A1 (de) 2000-08-02
CA2306399A1 (en) 1999-04-22
WO1999018954A1 (en) 1999-04-22
EP1023062B1 (de) 2002-12-18
ATE229804T1 (de) 2003-01-15
EP1023062A4 (de) 2001-11-21
JP2001519389A (ja) 2001-10-23

Similar Documents

Publication Publication Date Title
DE60112942D1 (de) Verbindungen zur behandlung der alzheimerischen krankheit
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE69807115T2 (de) Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
BG105600A (en) 13-membered azalides and their use as antibiotic agents
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
HK1033574A1 (en) Anitumor agents
PT992509E (pt) Novos derivados macrolidos
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE187956T1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
DE69810332D1 (de) Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ATE168697T1 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen
HK1082727A1 (en) 2" oxo-voruscharin and derivatives thereof
DE69614838T2 (de) Verfahren zur herstellung von anhydroecgonin-estern

Legal Events

Date Code Title Description
8332 No legal effect for de